Big diabetes investment for Bigfoot

Bigfoot Biomedical has secured $57 million in financing as it works toward commercialising its diabetes management program.

According to a press release, Madryn Asset Management provided the financing to develop the Bigfoot Unity diabetes management program designed to simplify and connect aspects of insulin management to enable personalised, proactive and remote patient care.

The Bigfoot Unity program features smartpen caps that provide insulin dose decision support, allowing patients to follow doctors’ orders simply.

“As our company prepares for commercialisation of the Bigfoot Unity System, we are pleased to partner with Madryn, a firm with demonstrated success identifying transformative technologies within the healthcare industry,” Bigfoot CEO Jeffrey Brewer said. “Their investment will enable us to scale our commercial efforts with greater speed and geographic reach. Bigfoot’s deep and respected investor base reflects a strong validation of our commitment to developing breakthrough solutions in diabetes care.”

Desang Diabetes Magazine is our free-to-receive digital journal (see below). We cover diabetes news, diabetes management equipment (diabetes ‘kit’ such as insulin pumps and continuous glucose monitoring equipment) and news about food suitable for a diabetic diet including a regular Making Carbs Count column. We just need your email address to subscribe you (it really is free, and you can easily unsubscribe should you wish to).
Sign me up!
Open publication
Buy a Desang kitbag

See our range of kitbags